Bladder Cancer

Loss of CHEK2 Predicts Progression in Stage pT1 Non-Muscle-Invasive Bladder Cancer (NMIBC). December 6, 2019

Sex Differences in Urothelial Bladder Cancer Survival. December 6, 2019

Preoperative Plasma Fibrinogen and D-dimer as Prognostic Biomarkers for Non-Muscle-Invasive Bladder Cancer. December 6, 2019

Quality of the diagnostic process in patients presenting with symptoms suggestive of bladder or kidney cancer: a systematic review. December 5, 2019

The use of perioperative chemotherapy in patients undergoing radical cystectomy for bladder cancer in Quebec (Canada), 2000-2016. December 5, 2019

Identification of Candidates for Salvage Therapy: The Past, Present, and Future of Defining Bacillus Calmette-Guérin Failure. December 5, 2019

Efficacy of Raman spectroscopy in the diagnosis of bladder cancer: A systematic review and meta-analysis. December 4, 2019

Salvage Therapy Using Bacillus Calmette-Guérin Derivatives or Single Agent Chemotherapy. December 4, 2019

Nuclear Factor-κB Overexpression is Correlated with Poor Outcomes after Multimodality Bladder-Preserving Therapy in Patients with Muscle-Invasive Bladder Cancer. December 4, 2019

Comparative Effectiveness of Intravesical BCG-Tice and BCG-Moreau in Patients With Non-muscle-invasive Bladder Cancer. December 3, 2019

High-grade T1 Urothelial Carcinoma: Where Do We Stand? December 3, 2019

Radical Cystectomy in Female Patients - Improving Outcomes. December 3, 2019

Salvage Therapy for Non-muscle-invasive Bladder Cancer: Novel Intravesical Agents. December 2, 2019

Current Clinical Trials in Non-muscle-Invasive Bladder Cancer: Heightened Need in an Era of Chronic BCG Shortage. December 2, 2019

Imaging in Localized Bladder Cancer: Can Current Diagnostic Modalities Provide Accurate Local Tumor Staging? December 2, 2019

Fewer tumour draining sentinel nodes in patients with progressing muscle invasive bladder cancer, after neoadjuvant chemotherapy and radical cystectomy. November 29, 2019

Intravesical Gene Therapy. November 29, 2019

Neoadjuvant Therapies for Bladder Cancer in Cisplatin-ineligible Patients: What Options Do We Have? November 29, 2019

The increased risk for thromboembolism pre-cystectomy in patients undergoing neoadjuvant chemotherapy for muscle-invasive urinary bladder cancer is mainly due to central venous access: a multicenter evaluation. November 28, 2019

Impact of Bladder Neck Involvement on Recurrence in Patients With Non-muscle-invasive Bladder Cancer: An Analysis Based on a Time-dependent Model. November 28, 2019

Page 1 of 319